Johns Hopkins Wilmer Eye Institute Receives $20 Million Donation from T. Boone Pickens Foundation Additional funding from the T. Boone Pickens Foundation will create additional Professorships for young researchers at [….]
Weekly Quick Hits (BioHealth Capital Region) – Week of May 8, 2023 By Sarah EllinwoodMay 12, 2023 Funding, Awards and Collaborations Maryland Stem Cell Research Commission (MSCRF) Announces Over $14 [….]
Weekly Quick Hits (BioHealth Capital Region) – Week of April 24, 2023 By Sarah Ellinwood, Alex Keown, and Mark TerryApril 28, 2023 Funding, Awards and Collaborations Quest Diagnostics Acquires Haystack [….]
Weekly Quick Hits (Greater Philly) – Week of March 27, 2023 By Mark Terry, Alex Keown, and Sarah EllinwoodMarch 31, 2023 A special thank you to everyone who came out [….]
WASHINGTON – Today, President Biden announced the appointment of seven distinguished clinicians and researchers to the National Cancer Advisory Board, which plays an important role in guiding the Director of the National Cancer Institute in setting the course for the national cancer research program. President Biden is committed to ending cancer as we know it – including by making sure his Administration is investing in research and development that will help advance breakthroughs to prevent, detect, and treat diseases like cancer. The National Cancer Advisory Board will compliment the Administration’s efforts to build on the spirit and learnings of the Cancer Moonshot, which President Biden led in the Obama-Biden Administration.
“Fiscal Year 2021 was an extraordinary one for Johns Hopkins Technology Ventures despite the challenges of the pandemic,” Executive Director Christy Wyskiel told BioBuzz in an email. “We took full advantage of the momentum from the last few years.”
Covid 19 Timeline Year 2020 *click article titles below to read original BioBuzz content from the past year MARCH 4/7/2020 Coronavirus Pandemic Good News Roundup Sheds Light Amidst Trying COVID-19 [….]
Over the past nine months, more than $7 billion in federal funding has poured into the BioHealth Capital Region aimed at the battle against COVID-19 and has shown a spotlight on the broad impact biopharma life science companies and academic institutions are making in the fight against the pandemic.
Graybug Vision files for $86 Million IPO on NASDAQ (GRAY)
For Ph.D. students, deciding to leave the familiar environment of academia to pursue a career in the industry can be daunting. Often, Ph.D. students are so engrossed in their academic work they are simply unsure of what non-academic opportunities are out there and don’t know how to explore or test these options.
